• SENSEX 78,079.96
    113.61 (+0.15%)
  • BANKNIFTY 57,635.25
    -250.60 (--0.43%)
  • UltraTech Cem.
    11,575.00 10,329.00(%)
  • JSW Energy
    562.05 617.30(%)
  • Urban Company
    146.00 201.00(%)
  • HDFC Bank
    724.45 722.00(%)
  • ICICI Bank
    1,406.60 1,187.55(%)
  • Reliance Industries
    1,307.10 1,250.55(%)
  • Larsen & Toubro
    4,070.00 4,440.00(%)
  • Bharti Airtel
    1,970.05 2,174.70(%)
  • Godrej Consumer
    938.90 1,308.40(%)
  • Netweb Technol.
    5,200.00 5,241.65(%)
  • Thyrocare Tech.
    594.30 342.55(%)
  • Fortis Health.
    904.95 1,105.00(%)
  • SBI
    1,073.20 798.60(%)
  • Astral
    1,599.00 1,767.95(%)
  • M & M
    3,440.00 3,840.00(%)
  • ITC
    279.50 426.50(%)
  • Cupid
    295.00 295.00(%)
  • Bajaj Finserv
    2,037.00 2,194.65(%)
  • Axis Bank
    1,215.30 1,041.30(%)
  • Solar Industries
    20,400.00 20,400.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Supriya Lifescience Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 75656.0
  • ISIN : INE07RO01027
813.50 -18 (-2.11%)
  • As on 14 Aug 2026 (EOD)

  • Today’s Low

    808.50

  • Today’s High

    859.60

  • Open

    831.05

  • Perv Close

    831.05

  • 52W Low

    545.50

  • 52W High

    1,085.00

Key Indicators

  • P/E(TTM)

    31.24

  • Mar.Cap (₹Cr.)

    6,547.28

  • Div & Yield %

    0.12

  • Book Value(₹)

    148.82

  • Debt-Equity Ratio

    -2.11

  • AGM Date

    13-Aug-2026

  • EPS

    26.03

  • P/E Ratio

    31.24

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    6,547.28

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.10

  • BV (₹)

    148.80

  • Sales( ₹ in Cr.)

    827.88

  • NP (in Cr.)

    209.47

  • NP Var(%)

    11.0

  • Div%

    50.0

  • CPS (₹)

    29.60

  • EPS (₹)

    26.00

  • Traded Value (₹ in Lakhs)

    6,545.26

  • 52 Week High

    1,085.00

  • 52 Week Low

    545.50

  • Price BSE

    813.0

  • Price NSE

    814.00

  • Market Capital( in Cr.)

    6,545.26

  • P/C Ratio

    27.50

  • P/E Ratio

    31.20

  • Price Vs.BV

    26.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 781.92 646.93 516.47 588.52 430.97 311.64
Excise Duty 85.44 76.59 55.53 58.47 39.76 0.00
Net Sales 696.48 570.34 460.94 530.05 391.21 311.64
Other Income 9.82 10.64 9.49 7.58 5.01 11.07
Stock Adjustments 21.26 -30.31 6.51 3.03 12.44 13.90
Total Income 727.56 550.67 476.94 540.66 408.66 336.61
EXPENDITURE :            
Raw Materials 232.44 191.43 187.32 198.83 140.57 152.38
Power and Fuel Cost 24.80 21.37 20.95 14.07 9.24 8.97
Employee Cost 80.52 67.64 55.58 49.08 32.76 18.88
Other Manufacturing Expenses 51.81 35.68 28.87 18.44 13.15 8.27
Selling and Administration Expenses 54.65 38.10 37.32 33.83 31.88 30.10
Miscellaneous Expenses 12.61 9.80 8.51 4.84 2.92 8.56
Employee Benefit Expenses 80.52 67.64 55.58 49.08 32.76 18.88
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 456.83 364.01 338.55 319.09 230.51 227.15
Operating Profit 270.73 186.65 138.38 221.56 178.15 109.45
Interest 1.81 5.15 3.08 4.20 4.08 6.85
Gross Profit 268.92 181.50 135.30 217.36 174.07 102.60
Depreciation 20.44 15.81 11.82 10.12 6.76 6.41
Profit Before Tax 248.48 165.69 123.48 207.24 167.31 96.19
Current Tax 56.66 37.10 30.68 52.19 43.02 25.07
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.87 9.48 2.95 3.25 0.69 -2.23
Reported Net Profit 187.96 119.11 89.86 151.81 123.59 73.35
Extraordinary Items -0.01 0.00 -0.08 0.00 0.00 0.00
Adjusted Net Profit 187.97 119.11 89.94 151.81 123.59 73.35
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -3.36
P & L Balance brought forward 600.45 486.16 401.13 253.72 134.08 79.08
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 6.44 4.83 4.83 4.39 3.96 14.64
P & L Balance carried down 781.97 600.45 486.16 401.13 253.72 134.43
Dividend 0.00 0.00 0.00 0.00 0.00 14.64
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 40.00 30.00 30.00 27.00 100.00
Dividend Per Share(Rs) 1.00 0.80 0.60 0.60 0.54 10.00
Earnings Per Share-Unit Curr 23.35 14.80 11.16 18.86 16.89 50.11
Earnings Per Share(Adj)-Unit Curr 23.35 14.80 11.16 18.86 - -
Book Value 123.84 101.31 86.91 76.50 36.70 101.84
Book Value(Adj)-Unit Curr 123.84 101.31 86.91 76.50 - -

Shareholding Pattern

  • Promoter Group

    68.30%

  • Public Share Holding

    31.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 54,967,815 68.30 54,967,815 5
Partnership Firms-Indian (Promoter & Group) 10 0.00 10 1
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 54,967,825 68.30 54,967,825 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 10 0.00 10 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,979,916 6.19 4,979,916 73
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,930,686 2.40 1,930,686 2
Mutual Funds / UTI 1,041,067 1.29 1,041,067 10
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,297,047 1.61 1,297,047 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,248,726 11.49 9,248,726 93
2] Non Institution
Bodies Corporate 1,749,209 2.17 1,749,209 405
Clearing Members 24,018 0.03 24,018 21
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 893,389 1.11 893,389 2,024
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 550,612 0.68 550,612 1,340
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,001,138 1.24 1,001,138 6
Individuals holding nominal share capital up to Rs. 1 lakh 11,859,761 14.74 11,859,761 78,117
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 10,496 0.01 10,496 3
Others 0 0.00 0 0
Sub Total 16,266,249 20.21 16,266,249 81,983
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 80,482,800 100.00 80,482,800 82,082

Company Background

Supriya Lifescience LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Supriya Lifescience Ltd
  • BSE Code : 75656.0
  • ISIN : INE07RO01027

  • Incorporation Year

    2008

  • Registered Office

    207/208 Udyog Bhavan
    Sonawala Road Goregaon (East), Mumbai,
    Maharashtra-400063

  • Telephone

    91-22-40332727

  • FAX

  • Chairman

    Satish Waman Wagh

  • Managing Director

    Satish Waman Wagh

  • Company Secretary

    Prachi Sathe

  • Auditor

    Kakaria & Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Supriya Lifescience Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Supriya Lifesci. 813.25 706.30 781.92 31.30 27.43
Abbott India 27,617.45 7,217.19 6,929.05 37.81 43.78
Astrazeneca Phar 7,791.60 2,304.07 2,275.58 114.84 27.86
P & G Health Ltd 5,922.40 944.52 934.17 27.55 71.75
Glaxosmi. Pharma 2,664.65 3,932.76 3,790.20 42.57 58.17
Cipla 1,461.00 20,102.60 18,979.95 38.40 13.88
Bliss GVS Pharma 512.60 773.53 729.81 56.21 12.51
Amrutanjan Healt 491.85 469.50 451.82 26.34 21.89
Fermenta Biotec. 459.55 474.15 450.25 21.45 18.77
Guj. Themis Bio. 347.45 152.47 150.80 77.73 27.21
Ambalal Sarabhai 41.28 19.52 3.94 28.87 6.77